136 related articles for article (PubMed ID: 20202822)
21. Rho-ROCK-dependent ezrin-radixin-moesin phosphorylation regulates Fas-mediated apoptosis in Jurkat cells.
Hébert M; Potin S; Sebbagh M; Bertoglio J; Bréard J; Hamelin J
J Immunol; 2008 Nov; 181(9):5963-73. PubMed ID: 18941185
[TBL] [Abstract][Full Text] [Related]
22. Cisplatin augments FAS-mediated apoptosis through lipid rafts.
Huang CR; Jin ZX; Dong L; Tong XP; Yue S; Kawanami T; Sawaki T; Sakai T; Miki M; Iwao H; Nakajima A; Masaki Y; Fukushima Y; Tanaka M; Fujita Y; Nakajima H; Okazaki T; Umehara H
Anticancer Res; 2010 Jun; 30(6):2065-71. PubMed ID: 20651352
[TBL] [Abstract][Full Text] [Related]
23. Resistance to Fas-mediated apoptosis in malignant tumours is rescued by KN-93 and cisplatin via downregulation of c-FLIP expression and phosphorylation.
Yang BF; Xiao C; Li H; Yang SJ
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1245-51. PubMed ID: 17973862
[TBL] [Abstract][Full Text] [Related]
24. Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses.
Konstantakou EG; Voutsinas GE; Karkoulis PK; Aravantinos G; Margaritis LH; Stravopodis DJ
Int J Oncol; 2009 Aug; 35(2):401-16. PubMed ID: 19578756
[TBL] [Abstract][Full Text] [Related]
25. Identification of a lysine-rich region of Fas as a raft nanodomain targeting signal necessary for Fas-mediated cell death.
Rossin A; Kral R; Lounnas N; Chakrabandhu K; Mailfert S; Marguet D; Hueber AO
Exp Cell Res; 2010 May; 316(9):1513-22. PubMed ID: 20298688
[TBL] [Abstract][Full Text] [Related]
26. Up-regulation of FLIP in cisplatin-selected HeLa cells causes cross-resistance to CD95/Fas death signalling.
Kamarajan P; Sun NK; Chao CC
Biochem J; 2003 Nov; 376(Pt 1):253-60. PubMed ID: 12911332
[TBL] [Abstract][Full Text] [Related]
27. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
Chatterjee D; Schmitz I; Krueger A; Yeung K; Kirchhoff S; Krammer PH; Peter ME; Wyche JH; Pantazis P
Cancer Res; 2001 Oct; 61(19):7148-54. PubMed ID: 11585748
[TBL] [Abstract][Full Text] [Related]
28. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).
Chopin V; Slomianny C; Hondermarck H; Le Bourhis X
Exp Cell Res; 2004 Aug; 298(2):560-73. PubMed ID: 15265702
[TBL] [Abstract][Full Text] [Related]
29. Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via Fas-dependent and Fas-independent pathways.
Jiang S; Song MJ; Shin EC; Lee MO; Kim SJ; Park JH
Hepatology; 1999 Jan; 29(1):101-10. PubMed ID: 9862856
[TBL] [Abstract][Full Text] [Related]
30. Fas-dependent and -independent mechanisms of cell death following DNA damage in human colon carcinoma cells.
Petak I; Tillman DM; Harwood FG; Mihalik R; Houghton JA
Cancer Res; 2000 May; 60(10):2643-50. PubMed ID: 10825136
[TBL] [Abstract][Full Text] [Related]
31. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.
Huerta S; Heinzerling JH; Anguiano-Hernandez YM; Huerta-Yepez S; Lin J; Chen D; Bonavida B; Livingston EH
J Surg Res; 2007 Sep; 142(1):184-94. PubMed ID: 17603079
[TBL] [Abstract][Full Text] [Related]
32. Taiwan cobra phospholipase A2-elicited JNK activation is responsible for autocrine fas-mediated cell death and modulating Bcl-2 and Bax protein expression in human leukemia K562 cells.
Chen KC; Liu WH; Chang LS
J Cell Biochem; 2010 Jan; 109(1):245-54. PubMed ID: 19937732
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S
Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130
[TBL] [Abstract][Full Text] [Related]
34. Ezrin, actin and cytoskeleton in apoptosis of esophageal epithelial cells induced by arsenic trioxide.
Shen ZY; Xu LY; Li EM; Li JT; Chen MH; Shen J; Zeng Y
Int J Mol Med; 2003 Sep; 12(3):341-7. PubMed ID: 12883650
[TBL] [Abstract][Full Text] [Related]
35. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells.
Fulda S; Sieverts H; Friesen C; Herr I; Debatin KM
Cancer Res; 1997 Sep; 57(17):3823-9. PubMed ID: 9288794
[TBL] [Abstract][Full Text] [Related]
36. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
Fulda S; Meyer E; Debatin KM
Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
[TBL] [Abstract][Full Text] [Related]
37. Fas signaling induces raft coalescence that is blocked by cholesterol depletion in human RPE cells undergoing apoptosis.
Lincoln JE; Boling M; Parikh AN; Yeh Y; Gilchrist DG; Morse LS
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2172-8. PubMed ID: 16639029
[TBL] [Abstract][Full Text] [Related]
38. STAT-1-independent upregulation of FADD and procaspase-3 and -8 in cancer cells treated with cytotoxic drugs.
Micheau O; Hammann A; Solary E; Dimanche-Boitrel MT
Biochem Biophys Res Commun; 1999 Mar; 256(3):603-7. PubMed ID: 10080945
[TBL] [Abstract][Full Text] [Related]
39. CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway.
Parlato S; Giammarioli AM; Logozzi M; Lozupone F; Matarrese P; Luciani F; Falchi M; Malorni W; Fais S
EMBO J; 2000 Oct; 19(19):5123-34. PubMed ID: 11013215
[TBL] [Abstract][Full Text] [Related]
40. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53.
Bush JA; Cheung KJ; Li G
Exp Cell Res; 2001 Dec; 271(2):305-14. PubMed ID: 11716543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
